ELISA: 1:10,000, IF: 1:200-1:1000, WB: 1:500-1:2000 Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
Supplied as a liquid in ascitic fluid containing 0.03 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C for short term storage. Store at -20 °C for long term storage.
Target
CDK1
(Cyclin-Dependent Kinase 1 (CDK1))
Andere Bezeichnung
Cdc2
Hintergrund
Cdc2 plays a key role in the control of the eukaryotic cell cycle, where it is required for entry into S-phase and mitosis. Cdc2 exists as a complex with both cyclin A and cyclin B. The best characterized of these associations is the Cdc2 p34 cyclin B complex, which is required for the G2 to M phase transition. Activation of Cdc2 is controlled at several steps including cyclin binding and phosphorylation of threonine 161. However, the critical regulatory step in activating Cdc2 during progression into mitosis appears to be dephosphorylation of Tyr15 and Tyr14. Phosphorylation at Tyr15 and inhibition of Cdc2 is carried out by WEE1 and MIK protein kinases while Tyr15 dephosphorylation and activation of Cdc2 is carried out by the Cdc25 phosphatase. The isoform Cdc2deltaT is found in breast cancer tissues. Furthermore, Cdc2/Cdk1 is a key mediator of neuronal cell death in brain development and degeneration. Synonyms: Monoclonal Cdc2 antibody, Anti-Cdc2 antibody, Cyclin dependent kinase 1 antibody, Cdk1 antibody, Cell division control protein 2 homolog antibody.